ATI-50002 topical solution

ATI-50002 · Aclaris Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ATI-50002 topical solution, covering 2019-12-11 to 2020-12-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution [Phase 2]